Filter News
Area of Research
- (-) Fusion and Fission (3)
- (-) Materials for Computing (1)
- Biology and Environment (5)
- Clean Energy (41)
- Computer Science (2)
- Electricity and Smart Grid (3)
- Functional Materials for Energy (1)
- Isotope Development and Production (1)
- Isotopes (25)
- Materials (19)
- National Security (6)
- Nuclear Science and Technology (5)
- Quantum information Science (1)
- Sensors and Controls (1)
- Supercomputing (6)
News Type
News Topics
- (-) Grid (2)
- (-) Isotopes (2)
- 3-D Printing/Advanced Manufacturing (7)
- Advanced Reactors (6)
- Artificial Intelligence (1)
- Bioenergy (2)
- Biology (2)
- Biomedical (3)
- Buildings (1)
- Chemical Sciences (8)
- Climate Change (1)
- Composites (2)
- Computer Science (8)
- Coronavirus (3)
- Critical Materials (1)
- Decarbonization (3)
- Energy Storage (8)
- Environment (3)
- Exascale Computing (1)
- Fossil Energy (1)
- Frontier (1)
- Fusion (22)
- High-Performance Computing (2)
- ITER (6)
- Materials (11)
- Materials Science (18)
- Microscopy (5)
- Nanotechnology (8)
- National Security (1)
- Net Zero (1)
- Neutron Science (6)
- Nuclear Energy (26)
- Partnerships (3)
- Physics (1)
- Polymers (6)
- Quantum Computing (1)
- Quantum Science (3)
- Security (2)
- Simulation (4)
- Space Exploration (1)
- Summit (1)
- Sustainable Energy (9)
- Transportation (7)
Media Contacts
“Three-Dimensional Breast Cancer Spheroids” submitted by radiotherapeutics researcher Debjani Pal is stunning. Brilliant blue dots pop from an electric sphere threaded with bright colors: greens, aqua, hot pink and red.
In fiscal year 2023 — Oct. 1–Sept. 30, 2023 — Oak Ridge National Laboratory was awarded more than $8 million in technology maturation funding through the Department of Energy’s Technology Commercialization Fund, or TCF.
ORNL and the Tennessee Valley Authority, or TVA, are joining forces to advance decarbonization technologies from discovery through deployment through a new memorandum of understanding, or MOU.
In experiment after experiment, the synthetic radioisotope actinium-225 has shown promise for targeting and attacking certain types of cancer cells.